IT – CLICK/SECUR Connectivity Test 7th of October 2007 (45/07)
September 14, 2007 10:34 ET
|
Derivatives
Connectivity Test 7th of October 2007 towards production environment
OMX Derivatives Market CLICK/SECUR PRODUCTION system will go live with a new hardware platform the 8th of October. There are NO...
Representatives From The National Law Journal to Ring the NASDAQ Stock Market Closing Bell
September 14, 2007 10:31 ET
|
Nasdaq, Inc.
ADVISORY, Sept. 14, 2007 (PRIME NEWSWIRE) --
What:
William L. Pollak, President and Chief Executive Officer of ALM Media,
will preside over the closing bell in honor of The National Law
...
NOTIFICATION OF A TRANSACTION OF A DIRECTOR IN ACCORDANCE WITH RULE 3.1.4R OF THE DISCLOSURE AND TRANSPARENCY RULES
September 14, 2007 10:30 ET
|
Old Mutual plc
NOTIFICATION OF A TRANSACTION OF A DIRECTOR IN ACCORDANCE WITH RULE 3.1.4R OF
THE DISCLOSURE AND TRANSPARENCY RULES
Old Mutual plc (the Company) announces that on 13 September 2007 Mr J H
Sutcliffe,...
Slēgtais investīciju fonds Parex Baltijas Nekustamā Īpašuma Fonds II iegādājies ēku Lietuvā
September 14, 2007 10:22 ET
|
Citadele Asset Management
Ar mērķi diversificēt investīciju portfeli 2007.gada 12.septembrī slēgtais
investīciju fonds Parex Baltijas Nekustamā Īpašuma Fonds II ar kompānijas
Colliers International starpniecību iegādājies...
Der indkaldes til ordinær generalforsamling i selskabet
September 14, 2007 10:17 ET
|
Nordic Blue Invest A/S
Der indkaldes til ordinær generalforsamling i selskabet
Viborg Håndbold Klub A/S
CVR-nr. 21441406.
Generalforsamlingen gennemføres
onsdag, den 19. september 2007 kl. 17.00
i Viborg Lounge...
Slēgtais investīciju fonds Parex Baltijas Nekustamā Īpašuma Fonds II iegādājies ”Palazzo Italia” ēku
September 14, 2007 10:15 ET
|
Citadele Asset Management
2007.gada III. ceturksnī slēgtais investīciju fonds Parex Baltijas Nekustamā
Īpašuma Fonds II iegādājies savā īpašumā nekustamo īpašumu Kr. Barona ielā 2,
Rīga, Latvija, kas sastāv no zemes gabala...
Research Update
September 14, 2007 10:14 ET
|
Novo Nordisk A/S
Phase 3 study confirms that liraglutide treatment leads to both
glucose and weight reduction with a low risk of hypoglycaemic events
Novo Nordisk today announced clinical results from the fourth of...
Fase 3-studie bekræfter, at behandling med liraglutide sænker både
blodsukker og vægt med lav risiko for hypoglykæmi
September 14, 2007 10:14 ET
|
Novo Nordisk A/S
Novo Nordisk offentliggør i dag kliniske resultater fra det fjerde af
i alt fem fase 3-studier med liraglutide - den humane GLP-1-analog
til dosering én gang dagligt. LEAD® 4-studiet har strakt sig...
Research Update
September 14, 2007 10:13 ET
|
Novo Nordisk A/S
Novo Nordisk today announced clinical results from the fourth of five phase 3 studies with liraglutide - the once-daily human GLP-1 analogue. The 26-week LEAD® 4 study is part of the LEAD®...
Fase 3-studie bekræfter, at behandling med liraglutide sænker både blodsukker og vægt med lav risiko for hypoglykæmi
September 14, 2007 10:13 ET
|
Novo Nordisk A/S
Efter en indkøringsperiode med metformin og rosiglitazone blev patienterne i studiet tilfældigt udvalgt til supplerende behandling med enten liraglutide eller placebo. Det gennemsnitlige HbA1c-niveau...
- January 06, 2025 05:39 ET Smart Sleep Monitor Market Report 2024-2028 & 2033: Expansion Driven by Rising Sleep Disorders and Technological Advancements in AI
- January 06, 2025 05:23 ET Mortgage Brokerage Services Industry Report 2024-2033, Competitive Analysis of JPMorgan Chase & Co, Federal National Mortgage Association, Wells Fargo, Fairway Independent Mortgage, & Rocket Mortgage